{"id":"https://openalex.org/W2132585437","doi":"https://doi.org/10.1517/14740338.5.5.631","title":"Potential side effects of renin inhibitors \u2013 mechanisms based on comparison with other renin\u2013angiotensin blockers","display_name":"Potential side effects of renin inhibitors \u2013 mechanisms based on comparison with other renin\u2013angiotensin blockers","publication_year":2006,"publication_date":"2006-08-15","ids":{"openalex":"https://openalex.org/W2132585437","doi":"https://doi.org/10.1517/14740338.5.5.631","mag":"2132585437","pmid":"https://pubmed.ncbi.nlm.nih.gov/16907653"},"language":"en","primary_location":{"id":"doi:10.1517/14740338.5.5.631","doi":"https://doi.org/10.1517/14740338.5.5.631","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.5.5.631","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110420284","display_name":"Huifang Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huifang Cheng","raw_affiliation_strings":["George M. O'Brien Kidney and Urologic Diseases Center and Division of Nephrology, Vanderbilt University School of Medicineand Nashville Veterans Affairs Hospital, Nashville, TN 37232, USA. huifang.cheng@vanderbilt.edu","George M. O'Brien Kidney and Urologic Diseases Center and Division of Nephrology, Vanderbilt University School of Medicineand Nashville Veterans Affairs Hospital, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George M. O'Brien Kidney and Urologic Diseases Center and Division of Nephrology, Vanderbilt University School of Medicineand Nashville Veterans Affairs Hospital, Nashville, TN 37232, USA. huifang.cheng@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]},{"raw_affiliation_string":"George M. O'Brien Kidney and Urologic Diseases Center and Division of Nephrology, Vanderbilt University School of Medicineand Nashville Veterans Affairs Hospital, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042782798","display_name":"Raymond Clement Harris","orcid":"https://orcid.org/0000-0001-8025-0883","observed_orcids":["https://orcid.org/0000-0001-8025-0883"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond C Harris","raw_affiliation_strings":["George M. O\u2019Brien Kidney and Urologic Diseases Center and Division of Nephrology, Vanderbilt University School of Medicineand Nashville Veterans Affairs Hospital, Nashville, TN 37232, USA. huifang.cheng@vanderbilt.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George M. O\u2019Brien Kidney and Urologic Diseases Center and Division of Nephrology, Vanderbilt University School of Medicineand Nashville Veterans Affairs Hospital, Nashville, TN 37232, USA. huifang.cheng@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7766,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.64557927,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"5","issue":"5","first_page":"631","last_page":"641"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.7950000166893005},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7450000047683716},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8569999933242798},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5960000157356262},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.5099999904632568},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6019999980926514},{"id":"https://openalex.org/keywords/kidney-disease-progression","display_name":"kidney disease progression","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8579918146133423},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.7599086761474609},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6014717221260071},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5677449703216553},{"id":"https://openalex.org/C2910553456","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin Receptor Blockers","level":4,"score":0.5555965304374695},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5163082480430603},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.5162010788917542},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.46903952956199646},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.44817790389060974},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4343835115432739},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.41797521710395813},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.4147111177444458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4046838879585266},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3597561717033386},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.27797746658325195}],"mesh":[{"descriptor_ui":"D000014","descriptor_name":"Abnormalities, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000092502","descriptor_name":"Renin Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005650","descriptor_name":"Fumarates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005650","descriptor_name":"Fumarates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006947","descriptor_name":"Hyperkalemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007022","descriptor_name":"Hypotension","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007177","descriptor_name":"Inappropriate ADH Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/14740338.5.5.631","doi":"https://doi.org/10.1517/14740338.5.5.631","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.5.5.631","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},{"id":"pmid:16907653","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16907653","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":100,"referenced_works":["https://openalex.org/W50828826","https://openalex.org/W150635151","https://openalex.org/W172695073","https://openalex.org/W180946569","https://openalex.org/W1522865154","https://openalex.org/W1931208941","https://openalex.org/W1971373200","https://openalex.org/W1971379814","https://openalex.org/W1974174019","https://openalex.org/W1975477137","https://openalex.org/W1979771115","https://openalex.org/W1980835308","https://openalex.org/W1981534354","https://openalex.org/W1984546703","https://openalex.org/W1991106789","https://openalex.org/W1993748602","https://openalex.org/W2000314850","https://openalex.org/W2001253024","https://openalex.org/W2004823995","https://openalex.org/W2007000110","https://openalex.org/W2014529967","https://openalex.org/W2015569360","https://openalex.org/W2015959379","https://openalex.org/W2019949818","https://openalex.org/W2021011733","https://openalex.org/W2022014516","https://openalex.org/W2022526496","https://openalex.org/W2024447378","https://openalex.org/W2027584909","https://openalex.org/W2029190141","https://openalex.org/W2030422223","https://openalex.org/W2039880240","https://openalex.org/W2045615482","https://openalex.org/W2045675189","https://openalex.org/W2046490760","https://openalex.org/W2047521555","https://openalex.org/W2049490211","https://openalex.org/W2051332153","https://openalex.org/W2052600761","https://openalex.org/W2055263171","https://openalex.org/W2056976690","https://openalex.org/W2060050520","https://openalex.org/W2061075125","https://openalex.org/W2063210769","https://openalex.org/W2071956375","https://openalex.org/W2072253789","https://openalex.org/W2074842084","https://openalex.org/W2077972817","https://openalex.org/W2079215736","https://openalex.org/W2081599586","https://openalex.org/W2083203440","https://openalex.org/W2085746985","https://openalex.org/W2087481758","https://openalex.org/W2090279005","https://openalex.org/W2093767567","https://openalex.org/W2093916182","https://openalex.org/W2094412628","https://openalex.org/W2094567178","https://openalex.org/W2094727696","https://openalex.org/W2095286376","https://openalex.org/W2100767767","https://openalex.org/W2107914594","https://openalex.org/W2112960231","https://openalex.org/W2120235169","https://openalex.org/W2121754021","https://openalex.org/W2122744112","https://openalex.org/W2126721368","https://openalex.org/W2127380586","https://openalex.org/W2130567407","https://openalex.org/W2131560593","https://openalex.org/W2132123447","https://openalex.org/W2134956175","https://openalex.org/W2136411657","https://openalex.org/W2137816721","https://openalex.org/W2138670606","https://openalex.org/W2140502259","https://openalex.org/W2143508846","https://openalex.org/W2145461177","https://openalex.org/W2146340209","https://openalex.org/W2149197585","https://openalex.org/W2149620192","https://openalex.org/W2151295696","https://openalex.org/W2156052955","https://openalex.org/W2157065367","https://openalex.org/W2160498423","https://openalex.org/W2164834486","https://openalex.org/W2165133881","https://openalex.org/W2166710642","https://openalex.org/W2261682020","https://openalex.org/W2312388685","https://openalex.org/W2312400976","https://openalex.org/W2313231090","https://openalex.org/W2326354230","https://openalex.org/W2418530292","https://openalex.org/W2461231278","https://openalex.org/W2469641336","https://openalex.org/W2568019769","https://openalex.org/W2588061926","https://openalex.org/W2615684303","https://openalex.org/W4317926763"],"related_works":["https://openalex.org/W2077736028","https://openalex.org/W2017125585","https://openalex.org/W2243611371","https://openalex.org/W2021746486","https://openalex.org/W2320914922","https://openalex.org/W145047508","https://openalex.org/W2081314213","https://openalex.org/W1979861449","https://openalex.org/W2415146823","https://openalex.org/W4239492609"],"abstract_inverted_index":{"Angiotensin":[0],"(Ang)":[1],"II":[2,111],"plays":[3],"important":[4],"roles":[5],"in":[6,40,65,76,113,121],"the":[7,24,71,89,129],"development":[8,25],"of":[9,26,93],"hypertension":[10],"and":[11,13,30,55,116],"cardiovascular":[12],"renal":[14,57],"injury.":[15],"Pharmaceutical":[16],"approaches":[17],"to":[18,23,50,107,117],"block":[19],"its":[20],"activity":[21],"led":[22],"angiotensin-converting":[27],"enzyme":[28],"inhibitors":[29,87,96],"angiotensin":[31],"receptor":[32],"blockers.":[33],"Numerous":[34],"trials":[35],"have":[36,104],"documented":[37],"their":[38],"efficacy":[39],"controlling":[41],"blood":[42,119],"pressure,":[43],"minimising":[44],"left":[45],"ventricular":[46],"remodelling,":[47],"preventing":[48],"progression":[49],"heart":[51],"failure,":[52],"ameliorating":[53],"proteinuria":[54],"retarding":[56],"disease":[58],"progression.":[59],"Although":[60],"they":[61],"are":[62],"considered":[63],"safe":[64],"general,":[66],"there":[67],"remain":[68],"concerns":[69],"about":[70,134],"potential":[72],"for":[73],"adverse":[74],"events":[75],"certain":[77],"target":[78],"populations.":[79],"Recently,":[80],"several":[81],"novel,":[82],"low":[83],"molecular":[84],"weight":[85],"renin":[86,95,136],"without":[88],"extended":[90],"peptide-like":[91],"backbone":[92],"previous":[94],"were":[97],"developed":[98],"with":[99,123],"favourable":[100],"pharmacokinetic":[101],"properties.":[102],"They":[103],"been":[105],"shown":[106],"successfully":[108],"reduce":[109],"Ang":[110],"levels":[112],"normal":[114],"volunteers":[115],"lower":[118],"pressure":[120],"patients":[122],"mild-to-moderate":[124],"hypertension.":[125],"In":[126],"this":[127],"review,":[128],"authors":[130],"summarise":[131],"current":[132],"knowledge":[133],"these":[135],"inhibitors.":[137]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}